{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:12:50Z","timestamp":1784628770308,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Stiftelsen Sj\u00f6grens syndrom","award":["."],"award-info":[{"award-number":["."]}]},{"DOI":"10.13039\/501100006075","name":"Greta och Johan Kocks stiftelser","doi-asserted-by":"publisher","award":["9420180916000"],"award-info":[{"award-number":["9420180916000"]}],"id":[{"id":"10.13039\/501100006075","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Reumatikerf\u00f6rbundet","doi-asserted-by":"publisher","award":["834211"],"award-info":[{"award-number":["834211"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00296-019-04335-3","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:27:17Z","timestamp":1559028437000},"page":"1575-1584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7318-833X","authenticated-orcid":false,"given":"Peter","family":"Olsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5206-4231","authenticated-orcid":false,"given":"Iris L. A.","family":"Bodewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3805-2290","authenticated-orcid":false,"given":"Carl","family":"Turesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart T. H.","family":"Jacobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Theander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0245-5386","authenticated-orcid":false,"given":"Marjan A.","family":"Versnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7143-7088","authenticated-orcid":false,"given":"Thomas","family":"Mandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"issue":"9482","key":"4335_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","volume":"366","author":"RI Fox","year":"2005","unstructured":"Fox RI (2005) Sjogren\u2019s syndrome. Lancet 366(9482):321\u2013331. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(05)66990-5","journal-title":"Lancet"},{"issue":"4","key":"4335_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/00005792-200207000-00003","volume":"81","author":"M Garcia-Carrasco","year":"2002","unstructured":"Garcia-Carrasco M, Ramos-Casals M, Rosas J, Pallares L, Calvo-Alen J, Cervera R, Font J, Ingelmo M (2002) Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore) 81(4):270\u2013280","journal-title":"Medicine (Baltimore)"},{"key":"4335_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key330","author":"J Imgenberg-Kreuz","year":"2019","unstructured":"Imgenberg-Kreuz J, Rasmussen A, Sivils K, Nordmark G (2019) Genetics and epigenetics in primary Sjogren\u2019s syndrome. Rheumatology (Oxford). \n                    https:\/\/doi.org\/10.1093\/rheumatology\/key330","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"4335_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/1573397112666160714164149","volume":"13","author":"P Sandhya","year":"2017","unstructured":"Sandhya P, Kurien BT, Danda D, Scofield RH (2017) Update on pathogenesis of Sjogren\u2019s syndrome. Curr Rheumatol Rev 13(1):5\u201322. \n                    https:\/\/doi.org\/10.2174\/1573397112666160714164149","journal-title":"Curr Rheumatol Rev"},{"issue":"5","key":"4335_CR5","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/rheumatology\/kex490","volume":"57","author":"ILA Bodewes","year":"2018","unstructured":"Bodewes ILA, Al-Ali S, van Helden-Meeuwsen CG, Maria NI, Tarn J, Lendrem DW, Schreurs MWJ, Steenwijk EC, van Daele PLA, Both T, Bowman SJ, Griffiths B, Ng WF, Versnel MA, registry UKPSsS (2018) Systemic interferon type I and type II signatures in primary Sjogren\u2019s syndrome reveal differences in biological disease activity. Rheumatology (Oxford) 57(5):921\u2013930. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/kex490","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"4335_CR6","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/annrheumdis-2012-201381","volume":"72","author":"Z Brkic","year":"2013","unstructured":"Brkic Z, Maria NI, van Helden-Meeuwsen CG, van de Merwe JP, van Daele PL, Dalm VA, Wildenberg ME, Beumer W, Drexhage HA, Versnel MA (2013) Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren\u2019s syndrome and association with disease activity and BAFF gene expression. Ann Rheum Dis 72(5):728\u2013735. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2012-201381","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"4335_CR7","doi-asserted-by":"publisher","first-page":"e0143970","DOI":"10.1371\/journal.pone.0143970","volume":"10","author":"K James","year":"2015","unstructured":"James K, Al-Ali S, Tarn J, Cockell SJ, Gillespie CS, Hindmarsh V, Locke J, Mitchell S, Lendrem D, Bowman S, Price E, Pease CT, Emery P, Lanyon P, Hunter JA, Gupta M, Bombardieri M, Sutcliffe N, Pitzalis C, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Griffiths B, Wipat A, Newton J, Jones DE, Isaacs J, Hallinan J, Ng WF, registry UKPSsS (2015) A transcriptional signature of fatigue derived from patients with primary Sjogren\u2019s syndrome. PLoS One 10(12):e0143970. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0143970","journal-title":"PLoS One"},{"issue":"1","key":"4335_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13075-017-1255-7","volume":"19","author":"P Olsson","year":"2017","unstructured":"Olsson P, Turesson C, Mandl T, Jacobsson L, Theander E (2017) Cigarette smoking and the risk of primary Sjogren\u2019s syndrome: a nested case control study. Arthritis Res Ther 19(1):50. \n                    https:\/\/doi.org\/10.1186\/s13075-017-1255-7","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"4335_CR9","doi-asserted-by":"publisher","first-page":"e0170249","DOI":"10.1371\/journal.pone.0170249","volume":"12","author":"DU Stone","year":"2017","unstructured":"Stone DU, Fife D, Brown M, Earley KE, Radfar L, Kaufman CE, Lewis DM, Rhodus NL, Segal BM, Wallace DJ, Weisman MH, Venuturupalli S, Brennan MT, Lessard CJ, Montgomery CG, Scofield RH, Sivils KL, Rasmussen A (2017) Effect of tobacco smoking on the clinical, histopathological, and serological manifestations of Sjogren\u2019s syndrome. PLoS One 12(2):e0170249. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0170249","journal-title":"PLoS One"},{"issue":"6","key":"4335_CR10","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3109\/s10165-011-0446-3","volume":"21","author":"G Karabulut","year":"2011","unstructured":"Karabulut G, Kitapcioglu G, Inal V, Kalfa M, Yargucu F, Keser G, Emmungil H, Gokmen NM, Kocanaogullari H, Aksu K (2011) Cigarette smoking in primary Sjogren\u2019s syndrome: positive association only with ANA positivity. Mod Rheumatol 21(6):602\u2013607. \n                    https:\/\/doi.org\/10.1007\/s10165-011-0446-3","journal-title":"Mod Rheumatol"},{"issue":"1","key":"4335_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1136\/ard.59.1.54","volume":"59","author":"R Manthorpe","year":"2000","unstructured":"Manthorpe R, Benoni C, Jacobsson L, Kirtava Z, Larsson A, Liedholm R, Nyhagen C, Tabery H, Theander E (2000) Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA\/Ro and anti-SSB\/La antibodies in Sjogren\u2019s syndrome? Ann Rheum Dis 59(1):54\u201360","journal-title":"Ann Rheum Dis"},{"issue":"5001","key":"4335_CR12","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1136\/bmj.2.5001.1071","volume":"2","author":"R Doll","year":"1956","unstructured":"Doll R, Hill AB (1956) Lung cancer and other causes of death in relation to smoking; a second report on the mortality of British doctors. Br Med J 2(5001):1071\u20131081","journal-title":"Br Med J"},{"issue":"11","key":"4335_CR13","doi-asserted-by":"publisher","first-page":"520","DOI":"10.4103\/0019-5359.58884","volume":"63","author":"DS Prasad","year":"2009","unstructured":"Prasad DS, Kabir Z, Dash AK, Das BC (2009) Smoking and cardiovascular health: a review of the epidemiology, pathogenesis, prevention and control of tobacco. Indian J Med Sci 63(11):520\u2013533. \n                    https:\/\/doi.org\/10.4103\/0019-5359.58884","journal-title":"Indian J Med Sci"},{"issue":"1","key":"4335_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/ard.2008.096487","volume":"69","author":"D Sugiyama","year":"2010","unstructured":"Sugiyama D, Nishimura K, Tamaki K, Tsuji G, Nakazawa T, Morinobu A, Kumagai S (2010) Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 69(1):70\u201381. \n                    https:\/\/doi.org\/10.1136\/ard.2008.096487","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4335_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.bpg.2003.12.003","volume":"18","author":"J Cosnes","year":"2004","unstructured":"Cosnes J (2004) Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterology 18(3):481\u2013496","journal-title":"Best Pract Res Clin Gastroenterology"},{"issue":"12","key":"4335_CR16","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/BF01536701","volume":"34","author":"BM Calkins","year":"1989","unstructured":"Calkins BM (1989) A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 34(12):1841\u20131854","journal-title":"Dig Dis Sci"},{"issue":"5 Suppl 24","key":"4335_CR17","first-page":"S77","volume":"19","author":"SW Rizvi","year":"2001","unstructured":"Rizvi SW, McGrath H Jr (2001) The therapeutic effect of cigarette smoking on oral\/genital aphthosis and other manifestations of Behcet\u2019s disease. Clin Exp Rheumatol 19(5 Suppl 24):S77\u2013S78","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"4335_CR18","doi-asserted-by":"publisher","first-page":"e95297","DOI":"10.1371\/journal.pone.0095297","volume":"9","author":"M van der Mark","year":"2014","unstructured":"van der Mark M, Nijssen PC, Vlaanderen J, Huss A, Mulleners WM, Sas AM, van Laar T, Kromhout H, Vermeulen R (2014) A case-control study of the protective effect of alcohol, coffee, and cigarette consumption on Parkinson disease risk: time-since-cessation modifies the effect of tobacco smoking. PLoS One 9(4):e95297. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0095297","journal-title":"PLoS One"},{"issue":"3","key":"4335_CR19","doi-asserted-by":"publisher","first-page":"J258","DOI":"10.1016\/j.jaut.2009.12.003","volume":"34","author":"Y Arnson","year":"2010","unstructured":"Arnson Y, Shoenfeld Y, Amital H (2010) Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 34(3):J258\u2013J265. \n                    https:\/\/doi.org\/10.1016\/j.jaut.2009.12.003","journal-title":"J Autoimmun"},{"issue":"6","key":"4335_CR20","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH (2002) Classification criteria for Sjogren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554\u2013558","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"4335_CR21","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/annrheumdis-2013-204615","volume":"74","author":"R Seror","year":"2015","unstructured":"Seror R, Theander E, Brun JG, Ramos-Casals M, Valim V, Dorner T, Bootsma H, Tzioufas A, Solans-Laque R, Mandl T, Gottenberg JE, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S, Valesini G, Bartoloni E, Saraux A, Tomsic M, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P, Vitali C, Mariette X, Bowman SJ, Force ESsT (2015) Validation of EULAR primary Sjogren\u2019s syndrome disease activity (ESSDAI) and patient indexes (ESSPRI). Ann Rheum Dis 74(5):859\u2013866. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2013-204615","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4335_CR22","doi-asserted-by":"publisher","first-page":"e000022","DOI":"10.1136\/rmdopen-2014-000022","volume":"1","author":"R Seror","year":"2015","unstructured":"Seror R, Bowman SJ, Brito-Zeron P, Theander E, Bootsma H, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dorner T, Ravaud P, Vitali C, Mariette X, Asmussen K, Jacobsen S, Bartoloni E, Gerli R, Bijlsma JW, Kruize AA, Bombardieri S, Bookman A, Kallenberg C, Meiners P, Brun JG, Jonsson R, Caporali R, Carsons S, De Vita S, Del Papa N, Devauchelle V, Saraux A, Fauchais AL, Sibilia J, Hachulla E, Illei G, Isenberg D, Jones A, Manoussakis M, Mandl T, Jacobsson L, Demoulins F, Montecucco C, Ng WF, Nishiyama S, Omdal R, Parke A, Praprotnik S, Tomsic M, Price E, Scofield H, Smolen J, Laque RS, Steinfeld S, Sutcliffe N, Sumida T, Valesini G, Valim V, Vivino FB, Vollenweider C (2015) EULAR Sjogren\u2019s syndrome disease activity index (ESSDAI): a user guide. RMD Open 1(1):e000022. \n                    https:\/\/doi.org\/10.1136\/rmdopen-2014-000022","journal-title":"RMD Open"},{"issue":"2","key":"4335_CR23","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/annrheumdis-2014-206008","volume":"75","author":"R Seror","year":"2016","unstructured":"Seror R, Bootsma H, Saraux A, Bowman SJ, Theander E, Brun JG, Baron G, Le Guern V, Devauchelle-Pensec V, Ramos-Casals M, Valim V, Dorner T, Tzioufas A, Gottenberg JE, Solans Laque R, Mandl T, Hachulla E, Sivils KL, Ng WF, Fauchais AL, Bombardieri S, Priori R, Bartoloni E, Goeb V, Praprotnik S, Sumida T, Nishiyama S, Caporali R, Kruize AA, Vollenweider C, Ravaud P, Meiners P, Brito-Zeron P, Vitali C, Mariette X, Force ESsT (2016) Defining disease activity states and clinically meaningful improvement in primary Sjogren\u2019s syndrome with EULAR primary Sjogren\u2019s syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Ann Rheum Dis 75(2):382\u2013389. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2014-206008","journal-title":"Ann Rheum Dis"},{"key":"4335_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/art.39859","volume":"25","author":"CH Shiboski","year":"2016","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X, International Sjogren\u2019s Syndrome Criteria Working G (2016) 2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sjogren\u2019s Syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 25:45. \n                    https:\/\/doi.org\/10.1002\/art.39859","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"4335_CR25","first-page":"378","volume":"25","author":"R Priori","year":"2007","unstructured":"Priori R, Medda E, Conti F, Cassara EA, Sabbadini MG, Antonioli CM, Gerli R, Danieli MG, Giacomelli R, Pietrogrande M, Valesini G, Stazi MA (2007) Risk factors for Sjogren\u2019s syndrome: a case-control study. Clin Exp Rheumatol 25(3):378\u2013384","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"4335_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.15644\/asc49\/4\/6","volume":"49","author":"N Petrusic","year":"2015","unstructured":"Petrusic N, Posavac M, Sabol I, Mravak-Stipetic M (2015) The effect of tobacco smoking on salivation. Acta Stomatol Croat 49(4):309\u2013315. \n                    https:\/\/doi.org\/10.15644\/asc49\/4\/6","journal-title":"Acta Stomatol Croat"},{"issue":"4","key":"4335_CR27","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/ALN.0b013e3181ebdaf9","volume":"113","author":"Y Shi","year":"2010","unstructured":"Shi Y, Weingarten TN, Mantilla CB, Hooten WM, Warner DO (2010) Smoking and pain: pathophysiology and clinical implications. Anesthesiology 113(4):977\u2013992. \n                    https:\/\/doi.org\/10.1097\/ALN.0b013e3181ebdaf9","journal-title":"Anesthesiology"},{"issue":"21\u201322","key":"4335_CR28","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1016\/j.febslet.2008.08.013","volume":"582","author":"WC HuangFu","year":"2008","unstructured":"HuangFu WC, Liu J, Harty RN, Fuchs SY (2008) Cigarette smoking products suppress anti-viral effects of Type I interferon via phosphorylation-dependent downregulation of its receptor. FEBS Lett 582(21\u201322):3206\u20133210. \n                    https:\/\/doi.org\/10.1016\/j.febslet.2008.08.013","journal-title":"FEBS Lett"},{"issue":"43","key":"4335_CR29","doi-asserted-by":"publisher","first-page":"17609","DOI":"10.1073\/pnas.1209724109","volume":"109","author":"JC Hall","year":"2012","unstructured":"Hall JC, Casciola-Rosen L, Berger AE, Kapsogeorgou EK, Cheadle C, Tzioufas AG, Baer AN, Rosen A (2012) Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases. Proc Natl Acad Sci USA 109(43):17609\u201317614. \n                    https:\/\/doi.org\/10.1073\/pnas.1209724109","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"4335_CR30","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/art.39204","volume":"67","author":"JC Hall","year":"2015","unstructured":"Hall JC, Baer AN, Shah AA, Criswell LA, Shiboski CH, Rosen A, Casciola-Rosen L (2015) Molecular subsetting of interferon pathways in Sjogren\u2019s syndrome. Arthritis Rheumatol 67(9):2437\u20132446. \n                    https:\/\/doi.org\/10.1002\/art.39204","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"4335_CR31","doi-asserted-by":"publisher","first-page":"e000282","DOI":"10.1136\/rmdopen-2016-000282","volume":"2","author":"N Howard Tripp","year":"2016","unstructured":"Howard Tripp N, Tarn J, Natasari A, Gillespie C, Mitchell S, Hackett KL, Bowman SJ, Price E, Pease CT, Emery P, Lanyon P, Hunter J, Gupta M, Bombardieri M, Sutcliffe N, Pitzalis C, McLaren J, Cooper A, Regan M, Giles I, Isenberg DA, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Griffiths B, Lendrem DW, Ng WF (2016) Fatigue in primary Sjogren\u2019s syndrome is associated with lower levels of proinflammatory cytokines. RMD Open 2(2):e000282. \n                    https:\/\/doi.org\/10.1136\/rmdopen-2016-000282","journal-title":"RMD Open"},{"key":"4335_CR32","doi-asserted-by":"publisher","first-page":"34356","DOI":"10.1038\/srep34356","volume":"6","author":"CC Liu","year":"2016","unstructured":"Liu CC, Gao YJ, Luo H, Berta T, Xu ZZ, Ji RR, Tan PH (2016) Interferon alpha inhibits spinal cord synaptic and nociceptive transmission via neuronal-glial interactions. Sci Rep 6:34356. \n                    https:\/\/doi.org\/10.1038\/srep34356","journal-title":"Sci Rep"},{"issue":"5","key":"4335_CR33","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2165\/00063030-200013050-00001","volume":"13","author":"S Shiozawa","year":"2000","unstructured":"Shiozawa S, Cummins JM, Fox PC (2000) Opening the flood gates: interferon-alpha treatment for Sjogren\u2019s syndrome. BioDrugs 13(5):305\u2013311. \n                    https:\/\/doi.org\/10.2165\/00063030-200013050-00001","journal-title":"BioDrugs"},{"issue":"8","key":"4335_CR34","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1089\/107999099313479","volume":"19","author":"JK Smith","year":"1999","unstructured":"Smith JK, Siddiqui AA, Modica LA, Dykes R, Simmons C, Schmidt J, Krishnaswamy GA, Berk SL (1999) Interferon-alpha upregulates gene expression of aquaporin-5 in human parotid glands. J Interferon Cytokine Res 19(8):929\u2013935. \n                    https:\/\/doi.org\/10.1089\/107999099313479","journal-title":"J Interferon Cytokine Res"},{"issue":"2","key":"4335_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/jama.2013.284692","volume":"311","author":"M Ng","year":"2014","unstructured":"Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, Wollum A, Sanman E, Wulf S, Lopez AD, Murray CJ, Gakidou E (2014) Smoking prevalence and cigarette consumption in 187 countries, 1980\u20132012. JAMA 311(2):183\u2013192. \n                    https:\/\/doi.org\/10.1001\/jama.2013.284692","journal-title":"JAMA"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04335-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04335-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04335-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,26]],"date-time":"2020-05-26T23:07:00Z","timestamp":1590534420000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04335-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["4335"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04335-3","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"19 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The current study was approved by the regional ethical review board for southern Sweden (Lund, Sweden: 2015\/311 and 2017\/94). All patients gave written informed consent in accordance with the declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}